Antares Therapeutics

Antares Therapeutics is a biotechnology company developing first-in-class precision medicines for cancer and other serious diseases. The company focuses on validated, undruggable targets with large unmet needs and is advancing a pipeline of small molecule assets, with its most advanced program expected to enter the clinic in 2026.

Funding Round: Series A

Funding Amount: $177M

Date: 10-Jun-2025

Investors: Omega Funds, Atlas Venture, Lightspeed Venture Partners, BVF Partners, Cormorant Asset Management, Vinyanshu Ventures, Abingworth, Invus, Tenmile, Vida Ventures, Willett Advisors

Markets: Biotech, Oncology, Medical, Pharmaceutical

HQ: Ewing, New Jersey, United States

Founded: 1979

Website: https://www.antaresrx.com/

LinkedIn: https://www.linkedin.com/company/antares-therapeutics

Twitter:

Instagram:

Facebook:

Crunchbase: https://www.crunchbase.com/organization/antares-pharma

Pitchbook: https://pitchbook.com/profiles/company/41941-72